Surprising Study Shows Plavix Raises Risk for Returning Ulcers
Posted on: Sunday, 23 January 2005, 12:00 CST
BOSTON -- Plavix, a heart drug recommended by medical groups as an easy-on-the-stomach substitute for aspirin, instead showed a much higher risk of recurrent ulcers in a small but provocative study.
The study could upend the treatment guidelines for tens of thousands of Americans who must take anti-clotting drugs for their hearts but are prone to gastrointestinal problems.
"These are very surprising findings, because the conventional wisdom is that Plavix is a GI-safe medicine -- or I should say 'has been' a GI-safe medicine," said Dr. Byron Cryer of the University of Texas Southwestern Medical School and Veterans Affairs hospital in Dallas.
He said he has stopped prescribing Plavix to his own patients who have a high risk of ulcers, but believes the drug is still OK for others.
He wrote an editorial to accompany the study, published in Thursday's New England Journal of Medicine.
The findings, reached by Hong Kong researchers, come as a surprise because Plavix was gentle on the stomach in previous testing. However, the patients in earlier research had a normal ulcer risk overall. This study was the first one to look at patients who had already had an ulcer.
An estimated 50 million Americans take aspirin, the inexpensive old standby, to ward off heart attacks and strokes. But aspirin can cause bleeding, ulcers or other stomach problems in perhaps a third of users.
Plavix is recommended as an alternative by the American Heart Association and American College of Cardiology. It is aggressively marketed on TV by Sanofi-Aventis and Bristol-Myers Squibb. In the one-year Hong Kong study, 320 patients with healed ulcers were given either aspirin or Plavix. The aspirin patients also took an acid- blocking drug to protect their stomachs.
In the Plavix group, bleeding ulcers came back in 13 patients, or 8 percent. Among those who took aspirin, only one had another ulcer, or less than 1 percent.
Web site: nejm.org
Source: Tulsa World
Related Articles
- Regular Aspirin Use Not Needed In Non-Risk Patients
- Cogent Trial Shows Lack Of Adverse Interaction Between Clopidogrel, Stomach Medicine
- SinoFresh Reports Patient Case Study: Allergic Fungal Rhinosinusitis in Adult Male With History of Sinus Conditions
- University of Pittsburgh Clinical Study to Test Antibody Therapy for Patients With Severe Ulcerative Colitis
- Most with heart risk don't use aspirin: study
- Putting Aspirin to Test: Accumetrics Helps Assess If Heart is Being Protected
- Genentech Stops Enrolling Patients in Study
- Study: Aspirin's Benefit to Women Mixed ; Stroke Risk Reduced, but Heart Attack Help Only in Those Over 65
- Study Shows Plavix Has Higher Ulcer Risk
- Aspirin Cuts Intestinal Polyps in At-Risk People
 |
 |
User Comments (0)
RSS Feeds